Systems biology has finally come of age. Evidence for this is the third Conference on Systems Biology of Mammalian Cells (SBMC), which will take place on June 3-5, 2010 at the Concert Hall Freiburg (Konzerthaus) under the auspices of Prof. Dr. Annette Schavan, German Federal Minister of Education and Research. HepatoSys/Virtual Liver, the network for systems biology of the liver, will host the conference and the Federal Ministry of Education and Research (BMBF) has provided funding.
For three days experts from all over the world will have the opportunity to exchange knowledge in the field of systems-biological analysis of processes in mammalian cells. But the focus will not only be on the newest technologies and revolutionary concepts: scientists will also present how medicine and pharmaceutical research already benefit from systems biology today – in particular, from the development of new and reliable drugs.A model to support decision-making
Medical-pharmaceutical research benefits above all from the systems-biological analysis of mammalian cells: simulations enable a better understanding of the dynamics of the complex disease promoting mechanisms and facilitate the exploration and development of more targeted therapies. The impact of drugs, too, can be simulated with the help of mathematical models, as they provide information on how an active pharmaceutical substance spreads within the body, how fast it metabolizes and, against this background, how it should be dosed. "However, it becomes really exciting at the point when you take the whole to the next higher level and start making decisions with the help of models regarding which pharmaceutical substances should be investigated further and studied, for instance, in clinical trials", Jörg Lippert of Systems Biology & Computational Solutions Bayer Technology Services GmbH in Leverkusen explains. Lippert’s team develops such simulations within the scope of HepatoSys/Virtual Liver.The computer simplifies the assessment
Against this background and in cooperation with the BMBF, the MTZ foundation from Erkrath near Dusseldorf promotes the young scientific generation in the field of systems biology. For the second time, three young scientists will be honored during the conference for their outstanding doctoral theses with the MTZ Award for medically oriented systems biology worth a combined total of 5,000 Euros.
Journalists are warmly invited to take part at the conference.About the SBMC
Sabine Trunz | idw
Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel
The Nagoya Protocol Creates Disadvantages for Many Countries when Applied to Microorganisms
05.12.2016 | Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
05.12.2016 | Power and Electrical Engineering
05.12.2016 | Materials Sciences
05.12.2016 | Power and Electrical Engineering